Abbott Labs (ABT) capital expenditure was $2.2B in FY2025 (-2% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2025
$2.2B
-2%
2024
$2.2B
+0%
2023
$2.2B
+24%
2022
$1.8B
-6%
2021
$1.9B
-13%
2020
$2.2B
+33%
2019
$1.6B
+18%
2018
$1.4B
+23%
2017
$1.1B
+1%
2016
$1.1B
+1%
2015
$1.1B
+3%
2014
$1.1B
-6%
2013
$1.1B
-36%
2012
$1.8B
+20%
2011
$1.5B
+47%
2010
$1.0B
-7%
2009
$1.1B
-15%
2008
$1.3B
-22%
2007
$1.7B
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q1 2026
$399M
Q4 2025
$689M
Q3 2025
$496M
Q2 2025
$502M
Q1 2025
$484M
Q4 2024
$720M
Q3 2024
$556M
Q2 2024
$533M
Q1 2024
$398M
Q4 2023
$755M
Q3 2023
$560M
Q2 2023
$507M
Source: ABT on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.